U.S. allows Actavis Plc's purchase of Forest Labs with conditions
June 30, 2014 at 17:12 PM EDT
WASHINGTON, June 30 (Reuters) - Pharmaceutical company Actavis Plc has won U.S. approval to buy Forest Laboratories on condition that it sell or relinquish the rights to four generic medicines, the Federal Trade Commission said on Monday.
